Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alda Corrado

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Experimental Cell Research|May 14, 2011
Peroxisome proliferator-activated receptor α agonists modulate Th1 and Th2 chemokine secretion in normal thyrocytes and Graves' diseaseAlessandro Antonelli, Silvia Martina Ferrari, Silvia Frascerra, et al.
Minerva Endocrinologica|June 27, 2015
Aggressive thyroid cancer: targeted therapy with sorafenibAlda Corrado, Silvia M Ferrari, Ugo Politti, et al.
Cytokine|May 24, 2011
Circulating chemokine (CXC motif) ligand (CXCL)9 is increased in aggressive chronic autoimmune thyroiditis, in association with CXCL10Alessandro Antonelli, Silvia Martina Ferrari, Silvia Frascerra, et al.
Clinical and Experimental Rheumatology|July 7, 2012
Chemokine (CXC motif) ligand 9 serum levels in mixed cryoglobulinaemia are associated with circulating levels of IFN-gamma and TNF-alphaAlessandro Antonelli, Poupak Fallahi, Silvia Martina Ferrari, et al.
Clinical Rheumatology|April 6, 2013
Parallel increase of circulating CXCL11 and CXCL10 in mixed cryoglobulinemia, while the proinflammatory cytokine IL-6 is associated with high serum Th2 chemokine CCL2Alessandro Antonelli, Poupak Fallahi, Silvia Martina Ferrari, et al.
World Journal of Diabetes|October 16, 2014
Hepatitis C virus infection and type 1 and type 2 diabetes mellitusAlessandro Antonelli, Silvia Martina Ferrari, Dilia Giuggioli, et al.
Surgery|August 25, 2014
Antineoplastic activity of the multitarget tyrosine kinase inhibitors CLM3 and CLM94 in medullary thyroid cancer in vitroSilvia Martina Ferrari, Poupak Fallahi, Concettina La Motta, et al.
Thyroid : Official Journal of the American Thyroid Association|April 2, 2020
Polymorphisms Within the <i>RET</i> Proto-Oncogene and Risk of Sporadic Medullary Thyroid CarcinomaFederica Gemignani, Cristina Romei, Raffaele Ciampi, et al.
Investigational New Drugs|December 10, 2020
Drug-repositioning screening identified fludarabine and risedronic acid as potential therapeutic compounds for malignant pleural mesotheliomaIrene Dell'Anno, Sarah A Martin, Marcella Barbarino, et al.
International Journal of Molecular Sciences|July 15, 2020
<i>EIF4G1</i> and <i>RAN</i> as Possible Drivers for Malignant Pleural MesotheliomaIrene Dell'Anno, Marcella Barbarino, Elisa Barone, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Experimental Cell Research|May 14, 2011
Peroxisome proliferator-activated receptor α agonists modulate Th1 and Th2 chemokine secretion in normal thyrocytes and Graves' diseaseAlessandro Antonelli, Silvia Martina Ferrari, Silvia Frascerra, et al.
Minerva Endocrinologica|June 27, 2015
Aggressive thyroid cancer: targeted therapy with sorafenibAlda Corrado, Silvia M Ferrari, Ugo Politti, et al.
Cytokine|May 24, 2011
Circulating chemokine (CXC motif) ligand (CXCL)9 is increased in aggressive chronic autoimmune thyroiditis, in association with CXCL10Alessandro Antonelli, Silvia Martina Ferrari, Silvia Frascerra, et al.
Clinical and Experimental Rheumatology|July 7, 2012
Chemokine (CXC motif) ligand 9 serum levels in mixed cryoglobulinaemia are associated with circulating levels of IFN-gamma and TNF-alphaAlessandro Antonelli, Poupak Fallahi, Silvia Martina Ferrari, et al.
Clinical Rheumatology|April 6, 2013
Parallel increase of circulating CXCL11 and CXCL10 in mixed cryoglobulinemia, while the proinflammatory cytokine IL-6 is associated with high serum Th2 chemokine CCL2Alessandro Antonelli, Poupak Fallahi, Silvia Martina Ferrari, et al.
World Journal of Diabetes|October 16, 2014
Hepatitis C virus infection and type 1 and type 2 diabetes mellitusAlessandro Antonelli, Silvia Martina Ferrari, Dilia Giuggioli, et al.
Surgery|August 25, 2014
Antineoplastic activity of the multitarget tyrosine kinase inhibitors CLM3 and CLM94 in medullary thyroid cancer in vitroSilvia Martina Ferrari, Poupak Fallahi, Concettina La Motta, et al.
Thyroid : Official Journal of the American Thyroid Association|April 2, 2020
Polymorphisms Within the <i>RET</i> Proto-Oncogene and Risk of Sporadic Medullary Thyroid CarcinomaFederica Gemignani, Cristina Romei, Raffaele Ciampi, et al.
Investigational New Drugs|December 10, 2020
Drug-repositioning screening identified fludarabine and risedronic acid as potential therapeutic compounds for malignant pleural mesotheliomaIrene Dell'Anno, Sarah A Martin, Marcella Barbarino, et al.
International Journal of Molecular Sciences|July 15, 2020
<i>EIF4G1</i> and <i>RAN</i> as Possible Drivers for Malignant Pleural MesotheliomaIrene Dell'Anno, Marcella Barbarino, Elisa Barone, et al.
Pageof 3